期刊文献+

Prevalence of Latent Tuberculosis (LTB) among Household Contacts of Newly Diagnosed Omani Pulmonary Tuberculosis Patients 被引量:2

Prevalence of Latent Tuberculosis (LTB) among Household Contacts of Newly Diagnosed Omani Pulmonary Tuberculosis Patients
下载PDF
导出
摘要 Background: Oman is a high-income, low prevalent country for tuberculosis disease. Although the rates have remained static over the last decade, the country is aiming for Tuberculosis (TB) elimination. Household contacts of pulmonary TB (PTB) patients form a high-risk group of susceptible individuals who could remain reservoirs of active disease. Objective: A retrospective study was conducted to estimate the prevalence of latent TB infection by Tuberculin Skin Test (TST) or Interferon-Gamma Release Assay (IGRA) screening tests among the household contacts of Omani patients with pulmonary tuberculosis. Design: A cross-sectional survey conducted between 2017 and 2018 of TB cases and their contacts in Muscat Governorate, Oman. Results: Out of the 278 contacts identified, 188 contacts fulfilled the inclusion criteria and were enrolled into the study. The prevalence of Latent Tuberculosis Infection (LTBI) was 22.8% (95% CI: 17.0 - 29.5) among household contacts. We found higher proportions of LTBI among females than males (28.7% vs. 15%, p = 0.027). Those who were exposed to Acid Fast Bacilli (AFB) smear positive cases were more likely to be LTBI (28.7% versus 15% in smear negative cases;p = 0.047). We also found an increasing trend of infection (32.3%) in the oldest age group (46 - 80 years). Conclusion: Besides children, female household contacts and older age contacts should be prioritized for screening as they are more likely to be infected and develop active disease. Background: Oman is a high-income, low prevalent country for tuberculosis disease. Although the rates have remained static over the last decade, the country is aiming for Tuberculosis (TB) elimination. Household contacts of pulmonary TB (PTB) patients form a high-risk group of susceptible individuals who could remain reservoirs of active disease. Objective: A retrospective study was conducted to estimate the prevalence of latent TB infection by Tuberculin Skin Test (TST) or Interferon-Gamma Release Assay (IGRA) screening tests among the household contacts of Omani patients with pulmonary tuberculosis. Design: A cross-sectional survey conducted between 2017 and 2018 of TB cases and their contacts in Muscat Governorate, Oman. Results: Out of the 278 contacts identified, 188 contacts fulfilled the inclusion criteria and were enrolled into the study. The prevalence of Latent Tuberculosis Infection (LTBI) was 22.8% (95% CI: 17.0 - 29.5) among household contacts. We found higher proportions of LTBI among females than males (28.7% vs. 15%, p = 0.027). Those who were exposed to Acid Fast Bacilli (AFB) smear positive cases were more likely to be LTBI (28.7% versus 15% in smear negative cases;p = 0.047). We also found an increasing trend of infection (32.3%) in the oldest age group (46 - 80 years). Conclusion: Besides children, female household contacts and older age contacts should be prioritized for screening as they are more likely to be infected and develop active disease.
出处 《Journal of Tuberculosis Research》 2020年第1期11-21,共11页 结核病研究(英文)
关键词 LATENT TB Infection INTERFERON Gamma Release ASSAY TUBERCULIN Skin Test Cavitary LESIONS Latent TB Infection Interferon Gamma Release Assay Tuberculin Skin Test Cavitary Lesions
  • 相关文献

参考文献1

二级参考文献18

  • 1刘玉清,屠德华,安燕生,张立兴.大学生结核病控制的研究:(二)结核感染者的预防性治疗[J].中国防痨杂志,2005,27(3):139-142. 被引量:95
  • 2张贺秋,赵雁林.现代结核病诊断技术.北京:人民卫生出版社,2013:47-103.
  • 3屠德华,万利亚,王黎霞.现代结核病控制理论与实践.2版.北京:军事医学科学出版社,2013:1-8.
  • 4Mack U, Migliori GB, Sester M, et al. LTBh latent tubercu- losis infection or lasting immune response to M. tuberculosis? A TBNET consensus statment. Eur Respir J, 2009,33 (5) : 956-973.
  • 5Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, Sexual Transmitted Diseases and Tuberculosis Prevention. Latent tuberculosis infection., a guide for primary health care providers. Atlanta: Centers for Disease Control and Prevention, 2013.
  • 6World Health Organization. Guidelines on the management of latent tuberculosis infection. WHO/HTM/TB/2015.01. Ge- neva.World Health Organization,2015.
  • 7Dye C, Scheele S, Dolin P, et al. Consensus statement. Glo- bal burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Mo- nitoring Project. JAMA, 1999, 282(7).677-686.
  • 8Gao XF, Wang L, Liu GJ, et al. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a me- ta-analysis. Int J Tubere Lung Dis, 2006, 10(10) : 1080-1090.
  • 9Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med, 2011, 365(23):2155-2166.
  • 10Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in ru- ral China: baseline results of a population-based, multieentre, prospective cohort study. Lancet Infect Dis, 2015, 15 (3): 310-319.

共引文献30

同被引文献23

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部